Drug-labels.com

ACH-Solifenacin Succinate: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
5 mg, 10 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - ACH-Solifenacin Succinate

ABOUT THIS MEDICATION

What the medication is used for:

ACH-Solifenacin Succinate is used in the treatment of overactive bladder in adults with symptoms of frequent and urgent need to urinate (urinary frequency, urinary urgency) with urine leakage (urge urinary incontinence).

What it does:

ACH-Solifenacin Succinate is a urinary antispasmodic medication that helps to relax the smooth muscle of the bladder which leads to reduction of the symptoms caused by overactive bladder.

When it should not be used:

You should not take ACH-Solifenacin Succinate:

  • If you are not able to empty your bladder (also called urinary retention).
  • If you have End-Stage Kidney Disease and require dialysis.
  • If you are not able to empty your stomach (also called gastroparesis).
  • If you have narrow-angle glaucoma (high pressure and pain in the eyes).
  • If you are allergic to solifenacin succinate or any of the other ingredients in ACH-Solifenacin Succinate. See ‘What the non-medicinal ingredients are’

What the medicinal ingredient is:

The medicinal ingredient in ACH-Solifenacin Succinate Tablet is ‘solifenacin succinate’.

What the non-medicinal ingredients are:

Each ACH-Solifenacin Succinate tablet contains the following inert ingredients: lactose monohydrate, maize starch, hypromellose, magnesium stearate, talc, polyethylene glycol and titanium dioxide with yellow ferric oxide (5 mg ACH-Solifenacin Succinate tablet) or red ferric oxide (10 mg ACH-Solifenacin Succinate tablet).

What dosage form it comes in:

ACH-Solifenacin Succinate is available in 5 and 10 mg tablets

WARNINGS AND PRECAUTIONS

Before you use ACH-Solifenacin Succinate, talk to your doctor or pharmacist if you:

  • Have stomach problems affecting passage and digestion of food, or severe constipation.
  • Have glaucoma.
  • Have difficulty urinating, or weak urine stream.
  • Have heart disease
  • Have a rare heart problem called QT/QTc prolongation or family history of QT/QTc prolongation.
  • Have kidney or liver problems.
  • Have reduced ability to sweat.
  • Are pregnant or planning to become pregnant. Women who might get pregnant should use an effective birth control method while taking ACH-Solifenacin Succinate.

  • Are breastfeeding or plan to breastfeed.

ACH-Solifenacin Succinate should not be given to children or adolescents.

ACH-Solifenacin Succinate may cause blurred vision and drowsiness. Do not drive a car, operate any machinery, or engage in any activities that require accurate vision and full attention.

In hot weather, ACH-Solifenacin Succinate can cause heat prostration (fever and heat stroke due to decreased sweating). Do not stay long in a hot environment while taking the drug. If you have any symptoms of heat prostration, keep yourself cool and drink a lot of water.

Angioedema (the symptoms include swelling of the face or tongue, difficulty breathing) and anaphylactic reactions (the symptoms include hives, difficulty breathing, abdominal cramps, rapid heartbeat and feeling faint), which could be life-threatening, have been reported in some patients taking solifenacin succinate. If you experience any of these symptoms, stop taking ACH-Solifenacin Succinate and see your doctor immediately.

INTERACTIONS WITH THIS MEDICATION

Before and while taking ACH-Solifenacin Succinate you should tell your doctor about your other medications, even the medicine you bought without prescription including vitamins and herbal supplements.

ACH-Solifenacin Succinate is known to have drug interactions with the following drugs: Drugs known to prolong the QT/QTc interval and/or cause torsade de pointes, drugs that decrease electrolyte levels, anticholinergic drugs, drugs that stimulate the motility of the gut such as metoclopramide, ketoconazole, clarithromycin, erythromycin, diclofenac, nefazodone, verapamil.

Drinking grapefruit juice with ACH-Solifenacin Succinate may increase your blood level of solifenacin.

PROPER USE OF THIS MEDICATION

Usual Dose:

5 mg daily. The daily dose may be increased to 10 mg following consultation with your doctor. Swallow the tablet whole with water.

ACH-Solifenacin Succinate can be taken with or without food.

Overdose:

If you think you have taken too much ACH-Solifenacin Succinate, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If a dose is missed, the next tablet should be taken as planned.

Doses should not be doubled to make up for a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The following side effects have been reported in clinical trials with solifenacin succinate:

Most common side effects: dry mouth and constipation

Common side effects: dry eyes, urinary retention, blurred vision, nausea, abdominal pain, indigestion, urinary tract infection.

The following side effects have been reported with the use of solifenacin succinate in worldwide post-marketing experience, although the frequency of events or a causal relationship with solifenacin succinate could not always be confirmed:

acid reflux, change in sense of taste decreased appetite, delirium, dizziness, dry skin, fast or irregular heartbeat, feeling sleepy, glaucoma, hallucination, headache, high potassium levels, hypersensitivity reactions, intestinal blockage, itchiness, kidney ailment, liver problems, muscle weakness, nasal dryness, voice disorder, severe skin scaling and redness, itching (exfoliative dermatitis), severe skin rash, itchiness and fever (erythema multiforme), swelling in the lower limbs and vomiting.

Tell your doctor or pharmacist if you have any side effects while taking ACH-Solifenacin Succinate. This includes any side effects not listed above.

SERIOUS SIDE EFFEC TS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
RareAbdominal pain√
Constipation for more than 3 days√
Urinary retention√
Very rareSwelling of the face or tongue, difficulty breathing√
Fast or irregular heartbeat√
Anaphylactic reactions (severe allergic reactions)√

HOW TO STORE IT

Keep ACH-Solifenacin Succinate and all other medications out of the reach and sight of children.

Store between 15°C - 30°C.

Do not keep medicine that is out of date or that you no longer need.

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about ACH-Solifenacin Succinate:

  • Talk to your healthcare professional
  • Find the full Product Monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); or by calling the sponsor Accord Healthcare Inc. at 1-866-296-0354.

    Accord Healthcare Inc.

    3535 boul. St. Charles, suite 704,

    Kirkland, QC, H9H 5B9,

    Canada

Last Revised: February 5, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02439344

Revision date stated in the text: February 5, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for ACH-Solifenacin Succinate

Rx or OTC
Prescription (Rx)?
DIN 02439344, 02439352
Schedule(s) PRESCRIPTION
Active ingredient(s) Solifenacin succinate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD08 Solifenacin
Company ACCORD HEALTHCARE INC
Current status Marketed
Current status date March 20, 2023
Strengths and forms
DIN Strength Dosage form(s) Current status
02439344 5 MG Tablet Marketed March 20, 2023
02439352 10 MG Tablet Marketed March 20, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.